Editor’s voice – October 2011

Rebecca Aris

pharmaphorum

With 2012 fast approaching, the past month’s efforts at pharmaphorum have been largely focused on thinking ahead and scheduling in some fresh content for the year to come. I’ve lined up some interesting new series and made sure that some of your current favourite regular articles won’t be going anywhere. But more on that later.

First, let’s look at the highlights of what’s been featured on the site in the past month. To sum up, we had:-

• With a big help from our friends at Red Sky Vision we were able to feature some expertly put together interviews of Alex Butler and Francis Namouk.

• A much debated controversial discussion on the true usefulness of Twitter by Rob Walton.

• Coverage of recent events. We featured reports from the HCA meeting, the PM Society’s Patient and Industry engagement event, Digipharm and the PM Society’s Digital Awards.

“With a big help from our friends at Red Sky Vision we were able to feature some expertly put together interviews of Alex Butler and Francis Namouk.”

• Voices from overseas authors looking at pharma in Egypt, Australia and India.

• Overviews of the current state of the Global protein therapeutics market and the generics industry.

• A lesson in leadership from Chris Stevenson and a reflection on the challenges for middle management by Jane Chin.

• Interviews addressing current issues in drug development and social media use from inside pharma.

• Advice on setting up your own pharma or biotech start-up company from new author Taffy Williams.

• Further pieces from popular series rare is different and mHealth Monthly Mashup.

• Our latest patient perspective and more thoughts around social media in pharma from out latest social pharma face – Denise Silber.

• A view of obesity from a fresh angle –  Jessica Bruggeman of Micromass used behavioural science to look at physicians’ attitudes towards obese patients.

So do take the time to have a read through any pieces that you may have missed throughout October.

A look at November…

In November we will again be featuring a minimum of five pieces per week. We like to keep some surprises up our sleeve but here are some snippets of what’s to expect in the coming month:-

• We have two more patient perspectives coming your way offering insights of how patients perceive pharma and what it can do to improve the patient experience.

• Adam Jacobs of Dianthus will be shattering some of the myths surrounding ghostwriting in his two part article.

• Our Expert review series will address the challenge of co-morbidities in the aging patient.

• We will be seeing more social pharma faces, hearing next month from Andrew Spong and Shwen Gwee.

• There’ll be more from our regular series: Rare is different, Tunnah’s musings, Pharma gets social and mHealth Monthly Mashup.

• Conference coverage of Digital pharma east and the American college of rheumatology annual scientific meeting.

“In addition to next month’s content we’ve been lining up some great new authors and series for 2012.”

…And beyond

In addition to next month’s content we’ve been lining up some great new authors and series for 2012. So it would seem that next year’s schedule is starting to shape up nicely – but that’s not to say that your input isn’t welcomed. If you have suggestions of topics, authors, series that we should be thinking about next year then do voice your thoughts! I don’t want to ruin any surprises but rest assured next year will be action packed with articles covering a range of topics in pharma from legal to therapeutic areas but you’ll have to wait to find out exactly what’s to be featured. Until next month, do keep sending me your suggestions – and enjoy!

About the author:

Rebecca Aris is Managing Editor of pharmaphorum, the dynamic online information and discussion portal for the pharmaceutical industry. For queries she can be reached through the site contact form or via Twitter @Rebecca_Aris.

What content would you like to see on pharmaphorum in 2012?